Cross-Sector entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ASEAN, the most common co-covered peer. The tracked stories average 2 original sources each. Takeda Pharmaceutical Company appears in 1 tracked Cross-Sector story from July 13, 2026.
1 verified story tracked
Last mentioned: Jul 13, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ASEAN, the most common co-covered peer. The tracked stories average 2 original sources each. Takeda Pharmaceutical Company appears in 1 tracked Cross-Sector story from July 13, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Takeda Pharmaceutical Company. Shared-story counts are live from our verified record — not editorial picks.
Takeda receives Indonesia’s first plasma fractionation license, part of a $30 million collaboration to build a domestic plasma ecosystem. The initiative aims to scale manufacturing of plasma-derived medicinal products, positioning Indonesia as a regional biopharma hub.
Source: Business Wire (ca) · Business Wire (ca)
